Published on Medical Design Technology (http://www.mdtmag.com)

Home > Cerulean reaches two milestones with lead compound

Cerulean reaches two milestones with lead compound

Mass High Tech: The Journal of New England Technology

Cerulean Pharma Inc. in Cambridge announced that it hit two milestones regarding trials of its lead drug candidate, CRLX101, in separate studies aimed at treating non-small cell lung cancer (NSCLC) and metastatic renal cell carcinoma (mRCC).

Source URL (retrieved on 05/18/2013 - 7:27pm): http://www.mdtmag.com/news/2012/07/cerulean-reaches-two-milestones-lead-compound?qt-video_of_the_day=0